Sirkku Jyrkkiö - UTU Research Portal

Sirkku Jyrkkiö

- Docent,
Faculty of Medicine (University of Turku)

sirkku.jyrkkio@utu.fi

Publications

7 of 9

Somatostatin receptor expression in lymphomas: a source of false diagnosis of neuroendocrine tumor at 68Ga-DOTANOC PET/CT imaging (2018)
- Acta Oncologica
Ruuska T, Ramírez Escalante Y, Vaittinen S, Gardberg M, Kiviniemi A, Marjamäki P, Kemppainen J, Jyrkkiö S, Minn H
(A1 Refereed original research article in a scientific journal)
Time trends and occupational variation in the incidence of testicular cancer in the Nordic countries (2018)
- BJU International
Outi Ylönen, Sirkku Jyrkkiö, Eero Pukkala, Kari Syvänen, Peter J. Boström
(A1 Refereed original research article in a scientific journal)
A predictive model of overall survival in patients with metastatic castration-resistant prostate cancer (2017)
- F1000Research
Mehrad Mahmoudian, Fatemeh Seyednasrollah, Liisa Koivu, Outi Hirvonen, Sirkku Jyrkkiö, Laura L. Elo
(A1 Refereed original research article in a scientific journal)
Assessing the utilization of radiotherapy near end of life at a Finnish University Hospital: a retrospective cohort study (2017)
- Acta Oncologica
Liisa K. Rautakorpi, Johanna M. Mäkelä, Fatemeh Seyednasrollah, Anna M. Hammais, Tarja Laitinen, Outi M. Hirvonen, Heikki Minn, Laura L. Elo, Sirkku M. Jyrkkiö
(A1 Refereed original research article in a scientific journal)
End-of-life chemotherapy use at a Finnish university hospital: a retrospective cohort study. (2017)
- Acta Oncologica
Liisa K. Rautakorpi, Fatemeh Seyednasrollah, Johanna M. Mäkelä, Outi M. Hirvonen , Tarja Laitinen, Laura L. Elo, Sirkku M. Jyrkkiö
(A1 Refereed original research article in a scientific journal)
How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer? (2017)
- European Urology
Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, Outi Hirvonen, Tarja Laitinen, Sirkku Jyrkkiö, Laura L. Elo
(B1 Non-refereed article in a scientific journal)
Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data (2017)
- Lancet Oncology
Guinney J, Wang T, Laajala TD, Winner KK, Bare JC, Neto EC, Khan SA, Peddinti G, Airola A, Pahikkala T, Mirtti T, Yu T, Bot BM, Shen L, Abdallah K, Norman T, Friend S, Stolovitzky G, Soule H, Sweeney CJ, Ryan CJ, Scher HI, Sartor O, Xie Y, Aittokallio T, Zhou FL, Costello JC, and the Prostate Cancer Challenge DREAM Community
(A1 Refereed original research article in a scientific journal)
Reply to Tuomas Mirtti and Tero Aittokallio's Letter to the Editor re: Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, et al. How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer? Eur Urol. 2017;71:838-40. Clinical Utility of Trial-estimated Prognostic Models. (2017)
- European Urology
Seyednasrollah F, Mahmoudian M, Rautakorpi L, Hirvonen O, Laitinen T, Jyrkkiö S, Elo LL
(B1 Non-refereed article in a scientific journal)
Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry (2016)
- Breast Cancer Research and Treatment
Wirtz RM, Sihto H, Isola J, Heikkila P, Kellokumpu-Lehtinen PL, Auvinen P, Turpeenniemi-Hujanen T, Jyrkkio S, Lakis S, Schlombs K, Laible M, Weber S, Eidt S, Sahin U, Joensuu H
(A1 Refereed original research article in a scientific journal)
Lymfoomien luokitus tarkentuu (2016)
- Lääkärilehti
Jyrkkiö Sirkku, Karjalainen-Lindsberg M-L, Malila N, Leppä S
(A2 Refereed review article in a scientific journal )